Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Gotch

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|December 4, 2004
Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivoJustin Stebbing, Brian Gazzard, Steve Patterson, et al.
AIDS (London, England)|September 10, 2003
Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Ornella Flore, et al.
Antiviral Therapy|August 3, 2007
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 diseaseAssia Samri, Ruth Goodall, Catherine Burton, et al.
Journal of Leukocyte Biology|April 1, 2005
Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjectsAnthony Kebba, Justin Stebbing, Samantha Rowland, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, et al.
Vaccine|May 6, 2008
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunizationLindvi Gudmundsdotter, Ann-Charlotte Boström, Catherine Burton, et al.
Blood|May 17, 2003
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptorJustin Stebbing, Brian Gazzard, Simon Portsmouth, et al.
Cell Research|July 1, 2004
Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patientsJustin Stebbing, Steve Patterson, Simon Portsmouth, et al.
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative UgandansAnthony Kebba, Pontiano Kaleebu, Jennifer Serwanga, et al.
AIDS Research and Treatment|April 15, 2011
CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI SubstudyJennifer Serwanga, Susan Mugaba, Auma Betty, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|December 4, 2004
Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivoJustin Stebbing, Brian Gazzard, Steve Patterson, et al.
AIDS (London, England)|September 10, 2003
Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Ornella Flore, et al.
Antiviral Therapy|August 3, 2007
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 diseaseAssia Samri, Ruth Goodall, Catherine Burton, et al.
Journal of Leukocyte Biology|April 1, 2005
Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjectsAnthony Kebba, Justin Stebbing, Samantha Rowland, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, et al.
Vaccine|May 6, 2008
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunizationLindvi Gudmundsdotter, Ann-Charlotte Boström, Catherine Burton, et al.
Blood|May 17, 2003
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptorJustin Stebbing, Brian Gazzard, Simon Portsmouth, et al.
Cell Research|July 1, 2004
Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patientsJustin Stebbing, Steve Patterson, Simon Portsmouth, et al.
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative UgandansAnthony Kebba, Pontiano Kaleebu, Jennifer Serwanga, et al.
AIDS Research and Treatment|April 15, 2011
CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI SubstudyJennifer Serwanga, Susan Mugaba, Auma Betty, et al.
Pageof 8